bs-42275P-APC [Conjugated Protein]
Recombinant Varicella-zoster virus gE protein, N-His, APC Conjugated
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Swiss Prot: Q9J3M8

Source: Recombinant Varicella-zoster virus gE protein is expressed in E.coli with N-His. It contains the amino acid sequence of 31-538/623

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Varicella Zoster Virus (VZV), a member of the human herpes virus family, causes two distinct clinical manifestations: childhood chickenpox(Varicella) and shingles (zoster). Varicella is the outcome of the primary infection with VZV, whereas, zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immunosuppressed individuals. VZV virons are spherical and 150-200 nm in diameter. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. Its DNA is a single linear, double strand molecule, 125,000 nt long.

Sequence: 31-538/623

Conjugation: APC

Excitation/ Emission: 650nm/660nm

Size: 100µg, 500µg, 20µg

Applications: Others

Predicted Molecular Weight: 59.8


Cross Reactive Species: Others

For research use only. Not intended for diagnostic or therapeutic use.